Preservation of FoxP3 (cid:1) Regulatory T Cells in the Peripheral Blood of Human Immunodeficiency Virus Type 1-Infected Elite Suppressors Correlates with Low CD4 (cid:1) T-Cell Activation (cid:1)

Elite suppressors (ES) are untreated human immunodeficiency virus type 1 (HIV-1)-infected individuals who maintain normal CD4 (cid:1) T-cell counts and control viremia to levels that are below the limit of detection of current assays. The mechanisms involved in long-term control of viremia have not been fully elucidated. CD4 (cid:1) CD25 (cid:1) regulatory T cells (Tregs) downmodulate chronic inflammation by suppressing the activation and proliferation of effector lymphocytes. We found that while Tregs were functional in ES and patients on highly active antiretroviral therapy (HAART), ES maintained high levels of Tregs in peripheral blood mononuclear cells whereas patients on HAART had evidence of Treg depletion. We also demonstrated that Tregs can serve as reservoirs for HIV-1 in vivo. These data suggest that both direct infection by HIV-1 and tissue redistribution are possible explanations for declining FoxP3 (cid:1) Tregs in progressive HIV-1 infection. Furthermore, the maintenance of Tregs may be one mechanism associated with the nonprogressive nature of HIV-1 infection in ES. CD4 (cid:1) CD25

[1]  D. Nixon,et al.  FOXP3 expressing CD127lo CD4+ T cells inversely correlate with CD38+ CD8+ T cell activation levels in primary HIV‐1 infection , 2008, Journal of leukocyte biology.

[2]  E. Campo,et al.  Redistribution of FOXP3-Positive Regulatory T Cells From Lymphoid Tissues to Peripheral Blood in HIV-Infected Patients , 2007, Journal of acquired immune deficiency syndromes.

[3]  O. Lambotte,et al.  HIV controllers: how do they tame the virus? , 2007, Trends in immunology.

[4]  David A. Price,et al.  Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover , 2007, The Journal of experimental medicine.

[5]  B. Walker,et al.  Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy. , 2007, Immunity.

[6]  R. Siliciano,et al.  Severe Depletion of CD4+ CD25+ Regulatory T Cells from the Intestinal Lamina Propria but Not Peripheral Blood or Lymph Nodes during Acute Simian Immunodeficiency Virus Infection , 2007, Journal of Virology.

[7]  D. Fuchs,et al.  Regulatory T-Cell Markers, Indoleamine 2,3-Dioxygenase, and Virus Levels in Spleen and Gut during Progressive Simian Immunodeficiency Virus Infection , 2007, Journal of Virology.

[8]  I. James,et al.  Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy , 2007, AIDS.

[9]  Asier Sáez-Cirión,et al.  HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype , 2007, Proceedings of the National Academy of Sciences.

[10]  E. Rosenberg,et al.  Fully Differentiated HIV-1 Specific CD8+ T Effector Cells Are More Frequently Detectable in Controlled than in Progressive HIV-1 Infection , 2007, PloS one.

[11]  H. Cao,et al.  Peripheral CD4 loss of regulatory T cells is associated with persistent viraemia in chronic HIV infection , 2007, Clinical and experimental immunology.

[12]  A. Fauci,et al.  Suppression of HIV-specific T cell activity by lymph node CD25+ regulatory T cells from HIV-infected individuals , 2007, Proceedings of the National Academy of Sciences.

[13]  C. Chougnet,et al.  HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS. , 2006, Blood.

[14]  A. Banham.  Cell-surface IL-7 receptor expression facilitates the purification of FOXP3(+) regulatory T cells. , 2006, Trends in immunology.

[15]  H. Stein,et al.  Mucosal but not peripheral FOXP3+ regulatory T cells are highly increased in untreated HIV infection and normalize after suppressive HAART. , 2006, Blood.

[16]  Mario Roederer,et al.  HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. , 2006, Blood.

[17]  L. Ratner,et al.  Foxp3 Represses Retroviral Transcription by Targeting Both NF-κB and CREB Pathways , 2006, PLoS pathogens.

[18]  J. Warmington,et al.  Interferon-Gamma Responses to Candida Recover Slowly or Remain Low in Immunodeficient HIV Patients Responding to ART , 2006, Journal of Clinical Immunology.

[19]  D. Watkins,et al.  Premature induction of an immunosuppressive regulatory T cell response during acute simian immunodeficiency virus infection. , 2006, The Journal of infectious diseases.

[20]  Jeffrey N. Martin,et al.  Phenotypic, Functional, and Kinetic Parameters Associated with Apparent T-Cell Control of Human Immunodeficiency Virus Replication in Individuals with and without Antiretroviral Treatment , 2005, Journal of Virology.

[21]  P. Massip,et al.  FOXP3 mRNA Levels are Decreased in Peripheral Blood CD4+ Lymphocytes From HIV-Positive Patients , 2005, Journal of acquired immune deficiency syndromes.

[22]  Michael D. George,et al.  Gut mucosal T cell responses and gene expression correlate with protection against disease in long-term HIV-1-infected nonprogressors. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[23]  S. Higasa,et al.  Relationship of CD4+CD25+ regulatory T cells to immune status in HIV-infected patients , 2005, AIDS.

[24]  N. Jones,et al.  Depletion of Regulatory T Cells in HIV Infection Is Associated with Immune Activation1 , 2005, The Journal of Immunology.

[25]  A. Rudensky,et al.  A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3 , 2005, Nature Immunology.

[26]  H. Boehmer,et al.  Mechanisms of suppression by suppressor T cells , 2005, Nature Immunology.

[27]  N. Shire,et al.  Cutting Edge: The Prevalence of Regulatory T Cells in Lymphoid Tissue Is Correlated with Viral Load in HIV-Infected Patients 1 , 2005, The Journal of Immunology.

[28]  A. Rudensky,et al.  Regulatory T cell lineage specification by the forkhead transcription factor foxp3. , 2005, Immunity.

[29]  Vipin Kumar,et al.  Homeostatic control of immunity by TCR peptide-specific Tregs. , 2004, The Journal of clinical investigation.

[30]  S. Rutz,et al.  Interleukin‐2 is essential for CD4+CD25+ regulatory T cell function , 2004, European journal of immunology.

[31]  S. Ziegler,et al.  CD25+CD4+ Regulatory T Cells from the Peripheral Blood of Asymptomatic HIV-infected Individuals Regulate CD4+ and CD8+ HIV-specific T Cell Immune Responses In Vitro and Are Associated with Favorable Clinical Markers of Disease Status , 2004, The Journal of experimental medicine.

[32]  S. Sakaguchi,et al.  Induction of antigen-specific immunologic tolerance by in vivo and in vitro antigen-specific expansion of naturally arising Foxp3+CD25+CD4+ regulatory T cells. , 2004, International immunology.

[33]  Mark S. Sundrud,et al.  HIV Infection of Naturally Occurring and Genetically Reprogrammed Human Regulatory T-cells , 2004, PLoS biology.

[34]  D. Nixon,et al.  Human CD4+ CD25+ Regulatory T Cells Control T-Cell Responses to Human Immunodeficiency Virus and Cytomegalovirus Antigens , 2004, Journal of Virology.

[35]  N. Roberts,et al.  Incomplete immune reconstitution after initiation of highly active antiretroviral therapy in human immunodeficiency virus-infected patients with severe CD4+ cell depletion. , 2003, The Journal of infectious diseases.

[36]  F. Ramsdell,et al.  An essential role for Scurfin in CD4+CD25+ T regulatory cells , 2003, Nature Immunology.

[37]  A. Rudensky,et al.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells , 2003, Nature Immunology.

[38]  T. Nomura,et al.  Control of Regulatory T Cell Development by the Transcription Factor Foxp3 , 2002 .

[39]  A. Freitas,et al.  Homeostasis of Peripheral CD4+ T Cells: IL-2Rα and IL-2 Shape a Population of Regulatory Cells That Controls CD4+ T Cell Numbers1 , 2002, The Journal of Immunology.

[40]  C. Hallahan,et al.  HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors , 2002, Nature Immunology.

[41]  T. Malek,et al.  CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2. , 2002, Immunity.

[42]  Ethan M. Shevach,et al.  CD4+CD25+ suppressor T cells: more questions than answers , 2002, Nature Reviews Immunology.

[43]  J. Bijlsma,et al.  Antigen‐specific T cell suppression by human CD4+CD25+ regulatory T cells , 2002, European journal of immunology.

[44]  Z. Grossman,et al.  CD4+ T-cell depletion in HIV infection: Are we closer to understanding the cause? , 2002, Nature Medicine.

[45]  G. Freeman,et al.  CD4+CD25high Regulatory Cells in Human Peripheral Blood1 , 2001, The Journal of Immunology.

[46]  M. Roncarolo,et al.  Human Cd25+Cd4+ T Regulatory Cells Suppress Naive and Memory T Cell Proliferation and Can Be Expanded in Vitro without Loss of Function , 2001, The Journal of experimental medicine.

[47]  Fiona Powrie,et al.  Cytotoxic T Lymphocyte–Associated Antigen 4 Plays an Essential Role in the Function of Cd25+Cd4+ Regulatory Cells That Control Intestinal Inflammation , 2000, The Journal of experimental medicine.

[48]  F. Marincola,et al.  HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[49]  Ethan M. Shevach,et al.  CD4+CD25+ Immunoregulatory T Cells Suppress Polyclonal T Cell Activation In Vitro by Inhibiting Interleukin 2 Production , 1998, The Journal of experimental medicine.

[50]  D. Montefiori,et al.  Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection. , 1997, The Journal of infectious diseases.

[51]  B. Walker,et al.  Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection. , 1996, AIDS research and human retroviruses.

[52]  D. Ho,et al.  Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. , 1995, The New England journal of medicine.